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A B S T R A C T
Beyond vitamin D (VD) effect on bone homeostasis, numerous physiological functions in human health have
been described for this versatile prohormone. In 2016, 95% of the world's population lived in areas where annual
mean ambient particulate matter (< 2.5 μm) levels exceeded the World Health Organization guideline value
(Shaddick et al., 2018). On the other hand, industries disperse thousands of chemicals continually into the
environment. Further, considerable fraction of populations are exposed to tobacco smoke. All of these may
disrupt biochemical pathways and cause detrimental consequences, such as VD deficiency (VDD). In spite of the
remarkable number of studies conducted on the role of some of the above mentioned exposures on VDD, the
literature suffers from two main shortcomings: (1) an overview of the impacts of environmental exposures on the
levels of main VD metabolites, and (2) credible engaged mechanisms in VDD because of those exposures. To
summarize explanations for these unclear topics, we conducted the present review, using relevant keywords in
the PubMed database, to investigate the adverse effects of exposure to air pollution, some environmental che-
micals, and smoking on the VD metabolism, and incorporate relevant potential pathways disrupting VD endo-
crine system (VDES) leading to VDD. Air pollution may lead to the reduction of VD cutaneous production either
directly by blocking ultraviolet B photons or indirectly by decreasing outdoor activity. Heavy metals may reduce
VD serum levels by increasing renal tubular dysfunction, as well as downregulating the transcription of cyto-
chrome P450 mixed-function oxidases (CYPs). Endocrine-disrupting chemicals (EDCs) may inhibit the activity
and expression of CYPs, and indirectly cause VDD through weight gain and dysregulation of thyroid hormone,
parathyroid hormone, and calcium homeostasis. Smoking through several pathways decreases serum 25(OH)D
and 1,25(OH)2D levels, VD intake from diet, and the cutaneous production of VD through skin aging. In sum-
mary, disturbance in the cutaneous production of cholecalciferol, decreased intestinal intake of VD, the mod-
ulation of genes involved in VD homeostasis, and decreased local production of calcitriol in target tissues are the
most likely mechanisms that involve in decreasing the serum VD levels.
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1. Introduction
Vitamin D is provided either through exposure to sunlight, which is
the main source or through intake from diet, which is supplementary
(Hansdottir et al., 2008; Holick, 2006). To sustain the human health,
the presence of a sufficient level of VD is compulsory. Insufficiency and
deficiency of VD have been reported in different climates and geo-
graphical regions. It is estimated that one billion individuals in the
world suffer from VD deficiency (VDD) in all age groups (Holick, 2007;
Holick and Chen, 2008). Accordingly, VDD has been identified as one of
the important public health concerns globally, and particularly in the
Middle East region (Palacios and Gonzalez, 2014). Due to the under-
lying role of this member of the steroid hormone family in biochemical
processes, VD has received a growing attention during the last decades.
Along with the understanding of VD metabolism, its related disorders
and therapeutic capabilities have been listed as one of the foremost
priorities for public health.
Although there is no precise estimation of the global burden of VD
deficiency, an array of investigations conducted by Lips and Van Schoor
provided a global overview of VD status. Based on studies performed on
the national status of VD around the globe, it turned out that VD de-
ficiency and insufficiency is very common in most countries, mainly in
the Middle East, India, China, and Mongolia. Lips and Van Schoor also
found that at risk groups for VDD include young children with low birth
weight, pregnant women, non-western immigrants and older in-
dividuals (Lips, 2010; Lips and van Schoor, 2011; Van Schoor and Lips,
2017). Studies have reported that VDD (<30 nmol/l) prevalence in
infants has been 86% in Iran, 61% in India, and 51% in Turkey (Roth
et al., 2018). As VDD is considered as a contributing factor to human
diseases, studying the interactions between VD metabolism and en-
vironmental agents seems to be noteworthy, especially to understand
links between environmental exposures and the pathogenesis of chronic
disorders. Although adequate exposure to inducible radiation of the sun
and adequate intake by dietary sources are key factors in maintaining
an acceptable level of VD, there is persuasive evidence demonstrating
that there are other environmental factors that interfere in VD endo-
crine systems (VDES). Therefore, studying the impacts of environmental
pollutants on VD metabolism seems necessary.
In 2016, 95% of the world's population lived in areas where ambient
particulate matter< 2.5 μm (PM2.5) levels exceeded the World Health
Organization guideline value of 10 μg/m3 (Shaddick et al., 2018). On
the other hand, industries disperse thousands of chemicals into en-
vironment. Further, considerable fraction of populations are exposed to
tobacco smoke. All of these may disrupt biochemical pathways and
cause detrimental consequences like VD deficiency (VDD). In addition,
we are in need of mechanistic studies to declare how exposure to these
exposures disrupt biochemical events and participate in the pathogen-
esis of disorders through decreasing the levels of active metabolites of
VD. In this study, we aimed to provide a mechanistic overview of the
aftermaths of exposure to air pollution, some environmental chemicals
and tobacco smoke related to dysfunctional VDES accompanied with
the declined serum levels of two main metabolites of VD including
25‑hydroxyvitamin D (25(OH)D, Calcifediol) and 1α,25‑dihydrox-
yvitamin D (1,25(OH)2D, Calcitriol).
2. Material and methods
Exposure to air pollution, some environmental chemicals, and
smoking, which are implicated directly or indirectly in disrupting VDES
and decreasing the serum levels of two main metabolites of VD were
investigated in this review. Briefly, the PubMed Database search was
performed on May 3nd 2018 using a combination of the following
keywords: (“Air Pollution”, “Heavy Metals”, “Endocrine Disruptors”,
“Halogenated Hydrocarbons”, “Bisphenol A” (BPA), “Phthalate”,
Fig. 1. The photosynthesis of ergocalciferol (D2) and cholecalciferol (D3). The upper process shows the synthesis of vitamin D2 from ergosterol with the help of UVB
radiation in plants and fungi. The lower process displays the photosynthesis of vitamin D3 from 7‑dehydrocholesterol (7‑DHC) in keratinocytes—the skin cells
responsible for the cutaneous production of vitamin D3.
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“Smoking”, “Tobacco Use”) AND (“Vitamin D”). Moreover, the re-
ference lists from included and relevant review articles were manually
searched. In order to include all available studies till the day, we used
Google Scholar as an additional source to fill in any probable gap.
Search strategy is presented in online Supplementary File 1.
There are numerous studies that have proposed the exposure to
tobacco smoke as one of lifestyle risk factors for VDD; however, we only
included those which had specifically focused on the relationship be-
tween smoking and the VD levels. Finally, 74 studies were included in
the review. Tables 1 and 2 provide a summary of the included articles in
this review.
3. Results and discussion
3.1. Synthesis of VD
As a member of the fat-soluble group of secosteroids (steroid mo-
lecules with a broken ring), VD plays a pivotal role in the metabolism of
calcium and phosphate, as well as, other biological processes. As it is
shown in the Fig. 1, there are two main types of VD including D2 (er-
gocalciferol) and D3 (cholecalciferol). Both of them could be provided
through exogenous sources. The former is originated from the ultra-
violet B (UVB) irradiation of the ergosterol in plants and fungi, and the
latter is found in the dietary sources, particularly in oily fish, and is
produced in the skin as well (the main and endogenous source) (Holick,
2006). Vitamin D3 can be synthesized in the skin without any enzymatic
reaction. It is produced from 7‑dehydrocholesterol (7‑DHC) via a two-
step process in which UV light (wavelengths of 290–315 nm) radiation
from the sun photolyzes 7‑DHC (provitamin D3) to precholecalciferol
(previtamin D3) in the plasma membrane of human skin keratinocytes.
Afterward, in a heat-dependent process, previtamin D3 instantly con-
verts to vitamin D3 (Holick, 2007). Skin pigmentation and UVB in-
tensity are two significant factors in the rate of vitamin D3 formation
(Holick et al., 1980; MacLaughlin et al., 1982). Thus, all factors which
may limit sun exposure (whether periodically or locally) can affect the
production of the VD.
D2, as the first VD analog, is structurally different from D3, resulting
in its lower affinity to VD-binding protein (DBP), which in turn leads to
its faster clearance from the circulation, limited conversion to the active
form, and altering catabolism by the enzyme 24‑hydroxylase
(CYP24A1) (Hollis, 1984; Houghton and Vieth, 2006). As a result, D2
supplementation does not result in high serum levels of VD as much as
D3 (Viljakainen et al., 2006).
3.2. VD metabolism
There are three main steps in the VD metabolism consisting of
25‑hydroxylation, 1α‑hydroxylation, and 24‑hydroxylation performed
by cytochrome P450 mixed-function oxidases (CYPs), enzymes located
in endoplasmic reticulum (ER) (e.g., CYP2R1) or in the mitochondria
(e.g., CYP27A1, CYP27B1, and CYP24A1) (Bikle, 2014). The mentioned
types of VD (D2 and D3) are physiologically inactive and therefore in
need of two sequential hydroxylations to turn into the biologically ac-
tive form (Fig. 2). After transportation of VD by DBP to the liver (the
major source of 25(OH)D production), it is hydroxylated by a number
of CYPs with 25 hydroxylase activity resulting in the formation of
25(OH)D (Christakos et al., 2010). Since a homozygous mutation of the
CYP2R1 gene has been observed in the patients with low circulating
levels of 25(OH)D and classic symptoms of VDD, it could be suggested
that CYP2R1 is the key enzyme required for 25‑hydroxylation of VD
(Cheng et al., 2004).
In the second step, 25(OH)D, as the major circulating form of VD
and the standard indicator of VD status, is transported to the kidney for
the next hydroxylation. 1α‑hydroxylase (CYP27B1) is the most abun-
dant enzyme which has the capability to hydroxylate the position of
carbon 1 of the A ring leading to the generation of the hormonally
active form of VD, 1,25(OH)2D. It should be pointed out that the kidney
is the major, if not the sole, source of circulating levels of 1,25(OH)2D
(Bikle, 2014). As it can be seen in the Fig. 2, low levels of calcium and
phosphate, as well as the elevated level of parathyroid hormone (PTH)
resulted from hypocalcemia stimulate the production of 1,25(OH)2D
(Murayama et al., 1999). As a result, increased levels of VD and calcium
cause diminishing expression of PTH and VD receptor (VDR). VDR as
the principal mediator is responsible for cellular effects of VD through
natural ligand with 1,25(OH)2D. Concisely, it can be said that
1,25(OH)2D levels are downregulated via its own production and the
level of serum calcium, while PTH induces its renal production (Bikle,
2014; Christakos et al., 2010).
The last but not least step in the metabolism of VD is that it is re-
sponsible for the hydroxylation of VD through the CYP24A1 which has
24‑hydroxylase activity and results in the water-soluble biologically
inactive calcitroic acid. Although the enzyme introduce hydroxyl into
both 25(OH)D and 1,25(OH)2D, the preferred substrate for 24(OH)ase
is 1,25(OH)2D (Omdahl et al., 2002; Shinki et al., 1992). Accordingly,
the control of 1,25(OH)2D level within tissues can be taken into account
as the foremost function of 24(OH)ase. This process can occur through
the catabolism of 1,25(OH)2D to 1,24,25(OH)3D or by decreasing the
reservoir of 25(OH)D via its catabolism to 24,25(OH)2D (Christakos
et al., 2010). This process may prevent VD intoxication which could
come from more than normal levels of 25(OH) and 1,25(OH)2D (Bikle,
2014).
3.3. Functions and disorders related to VD
Thanks to the extensive studies on the VD metabolism during the
last decades, there is growing evidence asserting the significant role of
VD inadequacy in the pathogenesis of a wide array of chronic diseases.
Even though there is no unanimity on the optimal level of serum
25‑hydroxyvitamin D (S-25(OH)D), there is an implicit agreement re-
garding the definition of VDD. Previous studies reported that S-25(OH)
D<20 ng/ml is considered as VD deficiency, 20 to 30 ng/ml is in-
sufficiency, 30 to 60 ng/ml is a sufficient level, and> 150 ng/ml is
intoxication (Holick, 2007, 2009).
Disturbance in the metabolism of the active form of VD
(1,25(OH)2D) is considered as a cause of VDD (Clements et al., 1992;
Holick, 2007). The conversion of the storage form of VD to its active
form stimulates the absorption of intestinal calcium and phosphate,
which in turn contribute to the bone health. This function of VD in the
homeostasis of calcium and phosphate plays an essential role in mus-
culoskeletal health as its deficiency could lead to osteoporosis, osteo-
malacia, decreased bone mineral density, and increased risk of fragility
fractures (Christodoulou et al., 2013). Potentially, the circulating levels
of 1,25(OH)2D affect functions of all tissues and cells possessing VDR,
particularly active T and B lymphocytes, breast, colon, prostate, and
heart skeletal muscle (Holick, 2006; Mathieu and Adorini, 2002; Nagpal
et al., 2005). Moreover, it has been observed that aside from kidney, a
broad range of tissues, mainly brain (neurons and glial cells), lung (lung
epithelial cells), colon (epithelial cells and parasympathetic ganglia),
prostate (normal (NP96-5), benign prostatic hyperplasia (BPH) cells),
skin (keratinocyte), and breast (normal lobules and ducts tissue), as
well as macrophages, have the capability to locally express 25‑hydro-
xyvitamin D‑1α‑hydroxylase, and produce 1,25(OH)2D. Therefore, they
regulate the expression of genes involving in their functions, especially
cell proliferation and differentiation (Bikle, 2011; Eyles et al., 2005;
Hansdottir et al., 2008; Schwartz et al., 1998; Townsend et al., 2005;
Zehnder et al., 2001). Thus, in addition to musculoskeletal con-
sequences of VD inadequacy, increasing experimental and epidemio-
logical evidence depicted that VDD can be involved in the pathogenesis
and/or progression of chronic illnesses, such as many common cancers
(colon, breast, and prostate) autoimmune diseases (multiple sclerosis
and type 1 diabetes mellitus, inflammatory bowel disease, systemic
lupus erythematosus), hypertension, cardiovascular diseases, and
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Fig. 2. VD endocrine system (VDES). VD is mainly synthesized in the skin cells and can be found in dietary sources as well. Through a two-stage hydroxylation
process, VD firstly converts to 25(OH)D and then is activated to 1,25(OH)2D. Liver and kidney are two principal organs where 25(OH)D and 1,25(OH)2D are
produced, respectively. With the help of DBP and circulating system, 1,25(OH)2D is transferred into the target organs possessing VD receptor (VDR) and results in
autocrine and endocrine actions.
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neurological disorders (Plum and DeLuca, 2010; Wang et al., 2017).
Based on the mentioned broad role of VD in human health and
adverse health effects derived from its deficiency, numerous efforts
have been made to evaluate its analogs in attenuation and treatment of
all aforementioned disorders. Antiproliferation, prodifferentiation, im-
munomodulation, antiangiogenesis, and apoptosis are among the most
protective functions that can be exerted by VD supplementations and
analogs (Adorini and Penna, 2008; Holick, 2006). Such noncalcemic
mechanisms are recruited by VD analogs, especially 1,25(OH)2D to
treat various types of disorders (Bikle, 2014). It has been shown that VD
analogs can be taken into account as preventative and therapeutic
agents by which the progression and risk of cancers (Deeb et al., 2007),
autoimmune diseases (Adorini and Penna, 2008), heart disorders, and
musculoskeletal illnesses would be reduced to a great extent (Plum and
DeLuca, 2010; Souberbielle et al., 2010).
3.4. Environmental contaminants
Owing to a plethora of studies performed on the detrimental health
effects of anthropogenic pollutants, solid evidence has been provided
during the last years associating VDD with exposure to environmental
contaminants including endocrine-disrupting chemicals (EDCs).
Interestingly, both EDCs exposure and VDD are heavily implicated in
adverse developmental, neurological, cardiovascular, metabolic and
immune effects in humans (Schug et al., 2011; Wang et al., 2017).
During the last decades, there has been an overwhelming urge
among researchers to investigate the possible health impacts posed by
EDCs and potential EDCs, which are anthropogenic toxic materials in
our environment, food, and consumer products. Pesticides, metals, bi-
sphenol A (BPA), phthalates, polycyclic aromatic hydrocarbons (PAHs),
and polyhalogenated compounds are on the top of the most damaging
EDCs, which damage human health (Frye et al., 2012). According to the
definition of U.S. Environmental Protection Agency (EPA), an endo-
crine-disrupting chemical is “an exogenous agent that interferes with
synthesis, secretion, transport, metabolism, binding action, or elim-
ination of natural blood-borne hormones that are present in the body
and are responsible for homeostasis, reproduction, and developmental
process” (Diamanti-Kandarakis et al., 2009). On the other hand, VD
should be considered as a prohormone that can be developed to its
hormonal form (1,25(OH)2D) through the VD endocrine system (VDES)
depicted in Fig. 2. All tissues possessing the enzyme 1α‑hydroxylase,
especially the kidney, could be taken into consideration as endocrine
glands which convert 25(OH)D to the hormonal form of 1,25(OH)2D. It
is noteworthy that investigators have shown>36 target organs with
VDR as a receptor for steroid hormone 1,25(OH)2D (Bouillon et al.,
1995; Norman, 2008).
EDCs have been shown to affect the biosynthesis pathways of
steroid hormone and thyroid hormone (TH) levels (Boas et al., 2012;
Sanderson, 2006). Since VD is similar to steroid hormones in terms of
molecular structure and biological functions and its nuclear receptor
belong to the same superfamily of proteins as steroid and thyroid
hormone receptors (Norman, 2008), it is highly likely that EDCs affect
VDES. Consequently, it seems plausible to state that all endocrine sys-
tems in general and VDES in particular, can be disrupted by environ-
mental chemical exposures. Such a deductive argument originates from
this fact that EDCs activate the same receptors and signaling pathways
as hormones and act at low concentrations. They are subjects to the
same biological regulatory systems as hormones (Schug et al., 2011).
As indoor and outdoor air pollutants, tobacco smoke, heavy metals
and persistent organic pollutants (POPs) can behave like EDCs, we in-
tend to incorporate all human and experimental studies that reported
rising prevalence of VDD and disruption of the VDES because of ex-
posure to these mentioned risk factors. To bring convincing associa-
tions, interactions between the chemicals and VDES will be mechan-
istically explained as far as studies provide enough evidence.
3.4.1. Air pollutants
As mentioned above, sun exposure plays an underlying part in VDES.
Therefore, every factor that has the potency to restrict the absorption of
sunlight by the skin would be capable of dysfunction in VD metabolism
fundamentally. Epidemiological and clinical studies represent an asso-
ciation between atmospheric pollution and hypovitaminosis D (Agarwal
et al., 2002; Baïz et al., 2012; Calderón-Garcidueñas et al., 2015;
Calderón-Garcidueñas et al., 2013; Hosseinpanah et al., 2010; Kelishadi
et al., 2014; Manicourt and Devogelaer, 2008). In megacities with a high
level of air pollutants, especially ozone, particulate matter (PM), and
sulfur dioxide, the UVB photons would be effectively absorbed by these
pollutants, diminishing the cutaneous photosynthesis of previtamin D3
(Gorham et al., 1989; Holick, 1995; Hoseinzadeh et al., 2018). This could
contribute to the modulation of immune responses subsequent to a
substantial decrease in the level of VD (Mousavi et al., 2017). In an in-
teresting cross-sectional study, Manicourt and colleagues evaluated in-
teractions between exposure to tropospheric ozone and sunlight affecting
the percentage of subjects with VD inadequacy in two groups of post-
menopausal women from Brussels or the countryside engaged in outdoor
activities. Participants did not differ in mean ages, body mass indices,
and VD intakes; nevertheless, urban residents were exposed to ozone
levels 3-fold higher than rural inhabitants. Notwithstanding that the
urban inhabitants benefited from higher mean sun exposure index (SEI)
than rural ones (113 vs. 87; P < 0.001), they had a higher prevalence of
25(OH)D<30 ng/ml (84% vs. 38%). It should be pointed out that after
adjusting for SEI, 25(OH)D was two times higher in rural residents, and
after adjusting for 25(OH)D, SEI was three times higher in urban re-
sidents (Manicourt and Devogelaer, 2008). In comparison to the coun-
tryside, residents in the urban areas with a high level of air pollution may
be discouraged from engaging outdoor activities leading to high pre-
valence of VDD (Bailey et al., 2012). Overall, results of Manicourt et al.
should be interpreted with caution as the ozone concentrations are ty-
pically higher in rural areas compared to urban areas as nitrogen oxides
originated from exhaust emissions scavenge the ozone and reduce it in
the urban areas (McConnell et al., 2006). However, some other local
conditions in Brussels might be responsible for the reported 3-fold higher
ozone concentrations compared with rural areas.
In a recent study performed in Mexico, it was reported that exposure
to high concentration of PM2.5 could lead to S-25(OH)D<30 ng/ml in
87% of Mexico City metropolitan area normal weight children compared
to controls (Calderón-Garcidueñas et al., 2015). In Mexico City, an en-
vironment characterized by ozone and PM levels above standard values
and decreased UV light, children had an insufficient VD intake and spent
less time outdoors than controls (P < 0.001) (Calderón-Garcidueñas
et al., 2013). Since it has been shown that air pollution is capable of
reducing UV light by 20% on average (Acosta and Evans, 2000) in
Mexico City, it could be inferred that in the setting of high concentration
of air pollutants, children have gotten less UV light exposure. Further-
more, spending less time outdoor synergistically reduce VD availability.
As a matter of fact, an atmospheric situation with a high level of pollu-
tants and dust causes high haze in which the visibility considerably re-
duces because of the decreased penetration of sunlight. It is proposed
that sunlight-blocking haze lessens the exposure to sun's VD inducing
radiations. Agarwal et al. compared the VD level of two comparable
groups of 9 to 24-month-old toddlers lived in two different areas of India
in terms of the level of atmospheric pollution. The mean serum con-
centration 25(OH)D of children from Mori Gate, well-known for a high
level of air pollution, was 12.4 ng/ml, compared with 27.1 ng/ml in
those who lived in Gurgaon area with less polluted air (P < 0.001).
Moreover, the mean haze score in the Mori Gate area (2.1) was sig-
nificantly lower (P < 0.05) than in the Gurgaon area (2.7), indicating
less solar UVB reaching the ground in Mori Gate (Agarwal et al., 2002).
Through the study of a cohort group in Paris, the relationship be-
tween gestational exposure to two urban air pollutants (PM10 and NO2)
and 25(OH)D cord blood serum level was inquired in 375 mother-child
pairs. Baïz and colleagues found that maternal exposure to the urban
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pollutants, in particular during late pregnancy, may contribute to lower
VD levels in offspring. After adjustment, log-transformed 25(OH)D
declined by 0.15 units (P= 0.05) and 0.41 units (P= 0.04) for an in-
crease of 10 ng/m3 in NO2 and PM10 pregnancy levels, respectively
(Baïz et al., 2012). Studies performed in Tehran and Isfahan, two high
air-polluted metropolises in Iran, also revealed that there is a negative
association between air quality and VD status (Hosseinpanah et al.,
2010; Kelishadi et al., 2014). Kelishadi and colleagues conducted a
cross-sectional study of 100 children aged 4–10 years from various
areas of Isfahan city with different levels of air pollution in order to
investigate the association between air quality index (AQI) and serum
concentration of 25(OH)D. After adjustment for age, gender, body mass
index (BMI), diet and pattern of physical activity, by a multiple linear
regression, they demonstrated an inverse association between AQI and
25(OH)D, which properly justified the high prevalence of VDD among
Isfahanian children. According to the data related to the dietary habits
obtained through validated questionnaires, they reported that dietary
intake of VD was not sufficiently low to explain the very low level of S-
25(OH)D (Kelishadi et al., 2014). In a similar study, Hosseinpanah et al.
compared two groups of healthy women from Tehran (higher-polluted
city) and Qazvin (lower-polluted city) concerning VD status. The
mean ± SD of S-25(OH)D level was markedly higher in Qazvinian
women (18 ± 11) compared with Tehranians (13 ± 7) (P-value <
0.001). The prevalence of severe VDD (25(OH)D<10 ng/ml) and
25(OH)D of 10–20 ng/ml among women in the high-polluted city were
36% and 54%, respectively, while they were estimated 31% and 32% in
women from Qazvin (Hosseinpanah et al., 2010).
3.4.2. Heavy metals
Due to the ubiquity of toxic metals in the environment and their role
as putative endocrine disruptors, it is necessary to study those metals
that can negatively affect steroid hormones, particularly VD. In this
regard, various studies have been demonstrated that heavy metals,
especially cadmium (Cd) and lead (Pb), as well as radioactive metals, in
particular, uranium (U) and 137cesium (137Cs) are capable of interfering
hormonal systems including VDES (Dyer, 2007).
3.4.2.1. Cadmium and lead. Since the kidney and liver as the principal
sources of the two main VD metabolites are included target organs for
Cd and Pb toxicity, diverse studies have been performed in this domain
in order to determine probable associations and mechanisms.
Cd is an environmentally widespread toxic metal with a long bio-
logical half-time in organs. The kidney, liver, bone, and cardiovascular
system are the main targets for Cd toxicity (Roe, 1993). According to a
series of human studies performed in the Cd-polluted areas of Japan,
exposure to environmental Cd causes perturbations in VDES (Nogawa
et al., 1990; Nogawa et al., 1987; Tsuritani et al., 1992). The most se-
vere form of Cd intoxication can be seen in patients with a bone disease
called itai-itai. These patients suffer from a painful bone damage
characterized by a combination of osteomalacia and osteoporosis, two
VDD-associated disorders. Nogawa et al. found decreased serum
1,25(OH)2D levels in itai-itai disease patients and Cd-exposed subjects
with kidney damage compared with non-exposed individuals (Nogawa
et al., 1987). As mentioned, the kidney is the main producer of circu-
lating 1,25(OH)2D; therefore, disturbance in its function can essentially
influence biological responses throughout the body via the deficiency of
the active form of VD. Reducing activity of enzyme involved in hy-
droxylating 25(OH)D to 1,25(OH)2D has been proposed as a possible
mechanism (Alfvén et al., 2000). The first toxic manifestation reported
in all human exposure to cadmium is renal tubular dysfunction. There is
growing evidence suggesting that kidney damage is the most likely
pathway by which an internal VDD could be occurred, which in turn
results in bone damage through a reduced level of calcium (Kido et al.,
1989). Tsuritani and colleagues suggested that this Cd-exposure-de-
rived consequence could lead to the impaired activation of VD as well
as an increase in the PTH level (Tsuritani et al., 1992). VDD is certainly
present in individuals with very low levels of total S-25(OH)D accom-
panied by hyperparathyroidism, hypocalcemia, or low bone mineral
density (BMD) (Powe et al., 2013). Among Cd-exposed women, a sig-
nificant correlation between serum 1,25(OH)2D and PTH levels with
indices of renal tubular dysfunction has been revealed (Tsuritani et al.,
1992). In an experimental study, 30 three-old-months female rats have
exposed to cadmium chloride in a dose of 50mg Cd/l in drinking water
for 3months. Results provided clear evidence that long-term exposure
to cadmium chlorine would inhibit renal 1‑α‑hydroxylase activity,
which resulted in reduction of the serum 1,25(OH)2D3 level (Youness
et al., 2012). In a similar study, Brzoska and colleagues depicted that
low lifetime exposure to CdCl2 can affect the metabolism of calciotropic
hormones, such as 1,25(OH)2D in female rats. Exposure to 1mg Cd/l in
drinking water for 24months, resulted in a significant depression in the
serum 25(OH)D and 1,25(OH)2D by 50 and 31%, respectively. The 55%
decrease in the kidney mitochondrial fraction in the exposed rats bol-
stered this theory that disorders in VD metabolism caused by exposure
to Cd are related to the kidney functional status (Brzóska and
Moniuszko-Jakoniuk, 2005). It seems that the decreased renal pro-
duction of 1,25(OH)2D is proportional to the progression of Cd-induced
renal tubular dysfunction (Keiko and Minoru, 1991). In agreement with
information provided by human and animal studies, WHO suggests that
Cd-induced bone effects may be mediated by renal tubular dysfunction,
which in turn leads to reduced activation of VD and decreased calcium
absorption from the gut (Organization, 2000; Roe, 1993).
The renal damage due to environmental Cd exposure can be lead to
elevated urinary levels of DBP as well (Kasuya, 2000). DBP plays a
critical role at VDES as it binds the principal VD metabolites (25(OH)D
and 1,25(OH)2D). DBP acts to bind and transport VD throughout the
body. DBP binds 88% of serum 25(OH)D and 85% of serum
1,25(OH)2D. DBP is also important for the renal activation of 25(OH)D
to 1,25(OH)2D(White and Cooke, 2000). Uchida et al. investigated the
relationship between urinary DBP levels and markers of renal tubular
dysfunction in the residents of a high Cd-polluted area (Cd group)
compared with people settled in the low Cd-polluted region (reference
group). They observed significantly higher levels of urinary DBP among
highly Cd-exposed individuals. Both Cd and reference groups showed
remarkable positive correlations between urinary level of DBP and
renal tubular dysfunction (Uchida et al., 2007). As urinary loss of DBP
may decrease the capacity for reabsorption and activation of VD in
proximal tubules, such deterioration of renal tubular function can jus-
tify the low level of 1,25(OH)2D under exposure to Cd (Berg, 1999). A
perturbation in the conversion of 25(OH)D to 24,25(OH)2D and
1,25(OH)2D has been reported under the situation of increased blood
and urinary Cd and blood Pb among smelter workers (Chalkley et al.,
1998). In several disorders, striking evidence distinguishes the role of
Pb intoxication in the daily intakes of VD and the concentrations of
hydroxylated metabolites of cholecalciferol (Anetor et al., 1999;
Arbuckle et al., 2016; Dongre et al., 2013; Edelstein et al., 1984;
Mazumdar et al., 2017; Rahman et al., 2018; Szabo et al., 1991).
Because of the extensive use of lead in different industries, most of
the existing Pb in our environment originates from human activities. Pb
is an endocrine modulator in human populations and is considered as
one of the risk factors of VDD (Dyer, 2007; Rahman et al., 2018). There
is adequate evidence that depicts lead poisoning would have similar
effects with Cd on the metabolic pathway of VD, especially in children
(Box et al., 1981; Chang et al., 2014; Mahaffey et al., 1982; Rosen et al.,
1980; Sorrell et al., 1977). Rosen and colleagues observed a significant
negative correlation between blood lead level (BLL) and serum
1,25(OH)2D among lead-burdened children. In one to five-year-old
children with increased blood concentration of Pb (33–120 μg/dl),
serum concentrations of 1,25(OH)2D were decreased to levels seen in
patients with hypoparathyroidism and metabolic bone disorders. The
level of active form of VD turned to the normal level when BLL declined
to< 30 μg/dl (Rosen et al., 1980). In a similar study performed by
these researchers on 177 1–16-year-old individuals, remarkable
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negative association (r=−0.88) was obtained between serum
1,25(OH)2D levels and the concentrations of blood lead over the entire
range of BLL (12 to 120 μg/dl). Adolescents aged between 11 and
16 years had serum 1,25(OH)2D levels higher than those observed
among children 10 years old or younger (Mahaffey et al., 1982). Such a
negative correlation was found between BLL and plasma 25(OH)D
below 8.32 ng/ml in Asian children (Box et al., 1981). It has been
suggested that further susceptibility of children to Cd and Pb could be
attributed to the gradual process of maturity in kidney from fetal period
to adulthood (Chalkley et al., 1998). An epidemiological study in China
investigated the prevalence of VDD and insufficiency related to BLL.
This cross-sectional study performed by Chang et al. confirmed the
negative correlation between 25(OH)D and BLL (r=−0.216,
P < 0.001). After multivariable adjustment, increasing child age,
especially between 8 and 14 years (OR=18.29; 95% CI 10.14, 32.99;
P < 0.001) and BLL (OR=1.01; 95% CI 1.00, 1.02; P= 0.045) were
the significant predictors of 25(OH)D deficiency and insufficiency
(Chang et al., 2014). In fact, this study affirmed some relationship be-
tween VD status and age-related accumulation of Pb in children.
It is of interest that intake of VD could be modulated by exposure to
lead. Through a cohort of 2001 pregnant women, it has been shown
that VD intake is negatively associated with maternal blood Cd, Pb, and
manganese (Mn), as well as cord blood Pb. Regression analysis de-
monstrated that higher intake of Ca and VD can be correlated with
lower maternal Pb and Cd concentration (Arbuckle et al., 2016). Sorrel
et al. reported an interesting chain of correlations among High BLL,
25(OH)D level, and VD intake that may be a rational justification for
the decreased serum levels of hydroxylated metabolites of cholecalci-
ferol under exposure to Pb. High BLL (≥60 μg/l) was associated with
the declined level of 25(OH)D in lead-burdened children (18 ± 1 ng/
ml) versus controls (32 ± 1 ng/ml). On the other hand, they figured
out a positive correlation between VD intake and S-25(OH)D as the high
blood Pb group had lower mean daily intakes of VD (210 ± 17 Inter-
national Unit (IU) vs. 325 ± 20 in controls, P < 0.001) (Sorrell et al.,
1977). As a result, a disturbance in the intake of VD can affect its serum
and kidney hydroxylated metabolites.
Recently, experimental data verified the destructive role of Pb ex-
posure in the metabolism of VD by affecting the expression of the in-
volved enzymes. For the first time, the impact of Pb on the serum levels
of VD metabolites, VD metabolizing enzymes (25‑hydroxylase and
1α‑hydroxylase), and VDR was observed in Wistar rats exposed to 0.2%
Pb-acetate via their dams' drinking water from post-natal day (PND) 1
to 21 and directly in drinking water until PND30. S-25(OH)D markedly
dropped at both PND21 and PND30, whereas 1,25(OH)2D was de-
creased (P < 0.05) only at PND21 in the Pb-exposed rats. Additionally,
renal 1‑α‑hydroxylase was decreased by Pb only at PND21 (P < 0.05)
but the brain 1α‑hydroxylase was not influenced. Hepatic expression of
25‑hydroxylase was substantially reduced at PND21 (Rahman et al.,
2018). In human studies, a dramatic decrease of 25(OH)D3 serum level
has been reported in jewelry workers compared with controls
(P < 0.0001) (Mazumdar et al., 2017), and of 1,25(OH)2D3 serum
level in battery manufacture workers (P < 0.01) (Dongre et al., 2013).
3.4.2.2. Uranium and cesium. U is an alpha-emitting heavy metal
occurring naturally in the earth's crust. Mining, energy industries, and
nuclear accidents are the main risk of exposure to depleted and
enriched uranium (DU and EU, respectively). Unfortunately, during
the last decades, environmental concentrations of U have been
increasing because of the growing use of this radionuclide in civil and
military applications. Ingestion, skin penetration, and inhalation are the
ways by which U can enter the body. Although a wide range of organs
can be targeted by chemical and radiological toxic impacts of U, its
major health effect is chemical kidney toxicity (ENDS, 2011).
In the case of U, according to the information provided by in vivo
studies, it also appears that disrupting of renal production of VD is the
underlying mechanism that interferes with VDES (Tissandié et al.,
2008; Tissandie et al., 2007; Tissandie et al., 2006b; Yan et al., 2011).
To investigate the impacts of DU on vitamin D3 metabolism, Tissandie
and colleagues chronically exposed rats to DU through drinking water
at 40ml/l for 9months. For the first time, this study demonstrated that
DU decreased plasma level of 1,25(OH)2D3 and VD receptor expression
in the kidney, resulting in the modulation of CYP24A1 expression and
VD target genes in calcium homeostasis. In addition to a small decrease
of 25(OH)D3 in plasma, low level of CYP27A1 (the gene encoding
25(OH)D3) has been observed in the brain of DU-exposed rats compared
to the controls (Tissandie et al., 2007). In a similar study, the significant
reduction of 1α‑hydroxylase in the kidney of rats has been reported
under chronic exposure to DU (Yan et al., 2011). Likewise, the chronic
exposure to EU influences both mRNA and protein expression of renal
nuclear receptors involved in the metabolism of VD (Tissandié et al.,
2008). Consistent with findings obtained from experimental investiga-
tions on rats, epidemiological studies on the effects of DU exposure on a
cohort of Gulf War veterans described elevated urinary levels of cal-
cium and altered serum levels of PTH and 1,25(OH)2D3 among DU-
exposed soldiers (McDiarmid et al., 2011; McDiarmid et al., 2008).
Hence, disturbance in renal functions related to VDES is expectable
under short- or long-term exposure to environmental DU and EU.
The explosion of Chernobyl nuclear power plant was a disaster that
released 137Cs in the environment and imposed serious health con-
sequences on the populations of contaminated areas, mainly through
the food consumption. This radioactive metal is formed in the fission
nuclear of fissionable isotopes in nuclear reactors and weapons. Chronic
contamination by 137Cs can impair the liver metabolism of cholesterol,
a precursor for the biosynthesis of steroid hormones, such as VD (Souidi
et al., 2006). Tissandie et al. designed a research to explore the biolo-
gical effects of chronic exposure to a post-accidental dose of 137Cs on
VD metabolism in liver, kidney, and brain. For this purpose, they en-
countered rats to the radioactive metal through drinking water for
3months at a dose of 6500 Bq/l (approximately 150 Bq/rat/day), a si-
milar concentration ingested by the people residing in contaminated
territories in the former Union of Soviet Socialist Republics countries.
Besides an insignificant decline in 25(OH)D3 and a drastic decrease in
1,25(OH)2D3 (53%, P= 0.02) in plasma, CYP2R1 (the key gene en-
coding 25(OH)D3) mRNA level (20%, P < 0.05) has exhibited a no-
ticeable drop in plasma level and brain. Nonetheless, the expression
level of CYP2R1 in the liver was increased by 40% (P < 0.05).
CYP27B1 mRNA level was declined in the brain by 20% (P < 0.05) as
well (Tissandie et al., 2006a). This research group continued their
metabolic studies on 137Cs. As children are known to be the most sus-
ceptible group for VD metabolism disorders, effects of 137Cs on VD
biosynthetic pathway were investigated in newborn rats. The experi-
ments were performed in 21-day-old male offspring of dams exposed to
137Cs under similar conditions with the previous study but during the
lactation period. Declined expression levels of CYP2R1 and CYP27B1
(−26 and −39%, respectively, P < 0.01) were reported in liver and
kidney (Tissandie et al., 2009). Further, a significant increase of
1,25(OH)2D3 and an unaffected level of 25(OH)D3 (similar to the pre-
vious study) has been reported in that study.
3.4.3. EDCs
Rapidly increasing evidence suggests that environmental pollutions,
particularly POPs possess an offensive capability to disrupt endocrine
systems. Biological and environmental accumulation, lipophilicity, hy-
drophobicity, and resistance to environmental degradation are common
traits of POPs, which include polychlorinated biphenyls (PCBs), poly-
chlorinated dibenzo‑p‑dioxins (PCDDs), polychlorinated dibenzofurans
(PCDFs), and organochlorine (OC) pesticides (Council, 2006). As men-
tioned above, since hormonally active VD metabolite and PTH have a
vital interrelated role in the optimal balance of phosphorous and calcium
for regulating bone mineralization, disrupting VD homeostasis may affect
skeletal development and bone metabolism (Fig. 2). In fact, 1,25(OH)2D-
simulated intestinal absorption and renal reabsorption of phosphate and
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calcium induces bone mineralization. Lowering the active metabolite of
VD bring about disturbances in bone mineralization and subsequently
progressive bone loss (Holick, 2006). There are a couple of field and
animal investigations showing the perturbations in VDES and decreased
serum levels of 25(OH)D and 1,25(OH)2D under exposure to POPs,
especially PCBs and Dichlorodiphenyltrichloroethane (DDT) (Alvarez-
Lloret et al., 2009; Fletcher et al., 2005; Ju et al., 2012; Lilienthal et al.,
2000; Routti et al., 2008).
In the first study of PCB-induced effects on vitamin D3 metabolites,
serum concentrations of 25(OH)D and 1,25(OH)2D were evaluated in
rat dams and offspring after exposure to a mixture of PCB reconstituted
based on the pattern of congeners found in human breast milk. Dose-
dependent reductions in serum levels of both VD metabolites were
observed in both dams and newborns. It should be added that even at
the lowest level of exposure (5mg PCB/kg diet), reductions of
1,25(OH)2D were seen in dams (Lilienthal et al., 2000). Also, it was
shown that embryonic exposure to 2,2′,3,3′,4‑pentachlorobiphenyl
(Arclor1254) have the capability to induce developmental deficits in
the zebrafish skeleton subsequent to changes in PTH and VDR expres-
sion (Ju et al., 2012). These outcomes suggest that exposure to POPs
could play an effective role in the VD metabolism. Non-maternal ex-
posure to POPs generates similar impacts. Through an experiment on
Baltic seals, Routti and colleagues perceived that thyroid system and VD
are initial targets for PCBs and DDT to disturb bone homeostasis. Gray
seals that were exposed to high levels of these chemicals have shown
decreased levels of 1,25(OH)2D and thyroid hormones, which were
negatively related to hepatic POPs. In accordance with the incorporated
information, the authors concluded that contaminant-mediated VD and
thyroid disruption might explain the bone lesions observed in the seals
(Routti et al., 2008). Similar findings were realized in the case of ex-
posure to dioxin-like PCBs. Using two cutting-edge techniques, namely
Fourier transform infrared spectrometry (FTIR), and transmission
electron microscopy (TEM), lower degree of mineralization (−8.5%;
P < 0.05) and undesirable changes in size and crystallinity were de-
tected in the vertebrae of rats exposed to 3,3′,4,4′,5‑penta-
chlorobiphenyl (PCB126) compared with controls (Alvarez-Lloret et al.,
2009). According to Norman (Norman, 2008), correct bone miner-
alization depends on VD-provided balance of calcium and phosphorous;
therefore, lower levels of thyroid hormones, and VD (−21%;
P < 0.005) seen in the rats exposed to PCB126 would potentially
contribute in bone dysfunction (Alvarez-Lloret et al., 2009).
Recent epidemiological studies indicate a correlation between re-
duction of serum VD levels and exposure to POPs (Morales et al., 2013;
Yang et al., 2012). In a Spanish population-based cohort, cross-sectional
association of S-25(OH)D3 (measured by gas chromatography) with the
serum concentration of eight POPs (measured by high-performance li-
quid chromatography) were examined in 2031 pregnant women. Mul-
tivariate regression models disclosed an inverse linear relationship be-
tween PCB180 and S-25(OH)D3 in which higher PCB180 levels were
associated with lower 25(OH)D3 level: quartile Q4 vs. quartile Q1,
coefficient=−1.59, 95% CI −3.27, 0.08, P trend=0.060. A non-
monotonic inverse association was also discovered between the sum of
predominant PCB congeners (PCB 180, 153 and 138) and 25(OH)D3
concentration: coefficient (95% CI) for quartile Q2 vs. Q1 [−0.50
(−1.94, 0.94)], quartile Q3 vs. Q1 [−1.56 (−3.11, −0.02)] and
quartile Q4 vs. Q1 [−1.21 (−2.80, 0.38)], P trend= 0.081 (Morales
et al., 2013). The role of POPs in the pathogenesis of chronically me-
tabolic disorders has been ascribed to their endocrine disrupting fea-
tures. Importantly, some of the mentioned diseases have been asso-
ciated with VDD. The first human study that linked the OC pesticides
and S-25(OH)D in human was performed by Yang and colleagues. They
sought the association between seven OC pesticides and S-25(OH)D in
the 1275 subjects aged> 20 years. Of measured pesticides, p,p′‑DDT
(β=−0.022, P < 0.01), p,p′‑DDE (β=−0.018, P=0.04), and
β‑HCH (β=−0.022, P=0.02) showed significant inverse associations
with S-25(OH)D levels (Yang et al., 2012). Based on the found inverse
association between PCBs and OC pesticides, it can be inferred that
background exposure to these chemicals may lead to lower level of
serum VD and probably VDD.
There is scarce human evidence of the destructive role of two main
endocrine disrupting agents, namely phthalate and BPA, in VDES
(Erden et al., 2014; Johns et al., 2017; Johns et al., 2016). Phthalate
and BPA are broadly utilized for the production of a vast range of in-
dustrial and consumer products. These environmental chemicals have
been extensively detected in the U.S. population. Johns et al. assessed
the relationship between phthalate and BPA and VD by data obtained
from a cross-sectional study with 4724 adults (aged ≥20 years). They
reported an inverse association between total S-25(OH)D and urinary
levels of di (2‑ethylhexyl) phthalate (DEHP) metabolites in the overall
population and urinary BPA only in women (Johns et al., 2016). This
finding was consistent with the remarked negative correlation between
serum BPA and S-25(OH)D reported among 128 patients with ob-
structive sleep apnea syndrome (OSAS) (Erden et al., 2014). Johns and
colleagues evaluated the relationship between urinary phthalate me-
tabolites and BPA and circulating total 25(OH)D in a large prospective
cohort of pregnant women with 477 participants. Repeated measures of
urinary DEPH metabolites and mono‑3‑carboxypropyl phthalate
(MCPP) were negatively correlated with total S-25(OH)D levels. A non-
significant inverse association was detected in the overall population
analysis between urinary and total 25(OH)D (Johns et al., 2017).
Carbon tetrachloride (CCl4), as a hepatotoxic solvent, is capable of
disrupting VDES. For the first time, Nussler et al. reported some dis-
turbances in the expression of genes involved in the VD metabolism.
The hepatic expression levels of CYP2R1, CYP27A1, and VD-binding
protein GC have significantly reduced in C27B16/N mice after 6-week
treatment with CCl4. They have also reported a meaningful increase in
7‑dehydrocholesterol reductase (DHCR7) gene expression in the liver
(Nussler et al., 2014). Since there is a direct correlation between the
expression of genes CYP2R1, CYP27A1, DHCR7 and GC with S-25(OH)
D levels in healthy populations (Bu et al., 2010; Wang et al., 2010), it
can be inferred that exposure to CCl4 is capable of significantly de-
creasing VD levels.
3.4.4. Contributions of environmental contaminations in most likely
mechanisms toward VDD
According to the conducted studies on the role of exposure to en-
vironmental pollutants in VDD until now (summarized in Table 1),
whether human or animal, a variety of mechanisms have been proposed
to interfere in VDES resulting in VD deficiency.
Sunlight exposure accounts for> 90% of VD production in human
beings (Hoseinzadeh et al., 2018). Despite the stated evidence, air
pollution might be an ignored risk factor while it is important for
dysregulating VDES at the early stage. As shown in the Fig. 3, air pol-
lutants could change the VD status directly and indirectly. Outdoor air
pollutants, especially ozone and PMs can limit UVB photons reaching
the ground through absorption of these sunlight's radiations. Thus, they
can affect the cutaneous production of precholecalciferol and finally
vitamin D3. Moreover, air pollution in certain situations may dis-
courage people to engage in daily outdoor activities. This can sy-
nergistically, and indirectly decrease the cutaneous production of VD.
Increases of hypovitaminosis D in populations, while benefiting
from enough dietary intakes of VD, makes environmental risk factors,
such as air pollution a culprit. Overall, increases in air pollutants con-
centrations, may diminish sunlight rays reaching the skin and conse-
quently lessen the cutaneous production of vitamin D3. Recent studies
reported that usage of sunscreens with higher sun protection factor
(SPF) in a regular basis could affect cutaneous production of VD among
those individuals that are living in air-polluted areas with sunny cli-
mates (Faurschou et al., 2012; Libon et al., 2017).
Other studies have reported that exposure to Cd and Pb could lead
to damages to kidney, especially renal tubular dysfunction and conse-
quently impair bone homeostasis (Dongre et al., 2013; Keiko and
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Minoru, 1991; Nogawa et al., 1987). Elevated urinary levels of DBP,
accumulation of heavy metal in the kidney, and decreased level of
1,25(OH)2D confirm such disturbances (Chalkley et al., 1998; Kido
et al., 1989; Uchida et al., 2007). In addition, experimental studies have
shown that the impaired renal activation of VD originates from the
dysregulation of renal 1α‑hydroxylase (Youness et al., 2012). Proximal
tubules including their mitochondria are the only sites of 1,25(OH)2D
biosynthesis in the kidney (Morgan, 2001). Mitochondria hydroxylases
are in charge of the renal conversion of 25(OH)D to 1,25(OH)2D
(Youness et al., 2012). Since Cd and Pd exposure are engaged in mal-
functioning mitochondria, the interaction of these toxic metals with the
resident hydroxylases in renal mitochondria can be an involved me-
chanism in VDD (Alfvén et al., 2000; Chalkley et al., 1998; Dongre
et al., 2013; Mazumdar et al., 2017; Youness et al., 2012). Altogether,
the renal tubular dysfunction and in particular the inhibition of the
renal 1α-hydroxylase enzyme are the most proposed pathways by
which Cd and Pb contribute to VDD (Fig. 3).
In the case of radionuclides U and 137Cs, based on conclusions de-
duced from in vivo studies in Table 1, exposure to these toxic metals
can affect the expression of CYPs enzymes that deal with VD metabo-
lism in liver and kidney, which results in the dysregulation of mineral
homeostasis. Such a chain of events could modulate the expression of
target genes by affecting the level of vitamin D3 active form (Tissandie
et al., 2006a, b). In fact, disrupting the renal production of VD is an
indirect pathway that affects bone development and maintenance. The
sustainable and well-balanced production of VD depends on the optimal
function of VDES shown in the Fig. 2. In fact, losing the balance be-
tween involved factors in VDES influences the serum level of VD me-
tabolites. In target organs of VD including kidney, bone, and intestine,
1,25(OH)2D binds to VDR and forms a heterodimeric complex with the
retinoic acid X receptor alpha (RXRα), the receptor for the 9‑cis retinoic
acid. This complex acts as a ligand-activated transcription factor by
altering the transcription rates of target genes, such as CYPs responsible
for VD metabolism (Tissandie et al., 2007; Tissandie et al., 2006b). VDR
activation by 1,25(OH)2D is a key factor in stimulating the intestinal
absorption of calcium and phosphorus, the renal reabsorption of
calcium, and other bone-related homeostatic processes. On the other
hand, the decreased expression of VDR and RXRα (the principal reg-
ulators of CYPs related to the VD metabolism) under exposure to U and
137Cs in animal studies has been reported (Tissandié et al., 2008;
Tissandie et al., 2009; Tissandie et al., 2007). Thus, the results obtained
by experimental studies can be interpreted that the reduced serum level
of 1,25(OH)2D originated from the decreased activity of CYP27B1 and
the decreased expression of receptors involved in VD metabolism are
two main factors that modulate ligand-activated transcription factor of
genes encoding proteins involved in VDES and finally end in VDD. Such
procedure is the case with Cd and Pb.
Having background exposure to POPs could be a determinant factor
in the pathogenesis of disorders that disrupt endocrine systems. As
shown in Table 1, bone-related parameters, as well as thyroid and VD
homeostasis, might be disturbed by exposure to EDCs. Vitamin D3, as a
secosteroid, is structurally similar to steroids, such as cholesterol, tes-
tosterone, and cortisol. Influence of PCBs on the activity and expression
of CYPs isomers, including those that catalyze the metabolism of steroid
hormone have been reported. Thus, the disruption of hepatic hydro-
xylation of cholecalciferol to 25(OH)D3 by the metabolites of PCBs
containing hydroxyl group is plausible and susceptible to VDD (Morales
et al., 2013). Theoretically, the inhibition of activity and expression of
CYPs involved in the metabolism of steroid and thyroid hormones
through exposure to EDCs depicts that CYPs interrelated to VDES could
be probable targets for these chemicals by which POPs exposure-de-
rived VDD observed in human and experimental models can be ex-
plained. As an indirect mechanism shown in Fig. 3, disrupting the
homeostasis of TH, PTH, and calcium under exposure to POPs leads to
chaos in bone metabolism and VDES and consequently the depression
of VD level (Alvarez-Lloret et al., 2009; Ju et al., 2012; Routti et al.,
2008). Perturbations in endogenous hormonal regulation stemmed
from exposure to EDCs could result in weight gain (Elobeid and Allison,
2008; Tang-Péronard et al., 2011) which in turn participates in the
hypovitaminosis D (Barrea et al., 2017; Johns et al., 2017; Pereira-
Santos et al., 2015).
Fig. 3. Possible biochemical pathways that air pollution, toxic metals, and EDCs may lead to VD deficiency (VDD). Decreasing outdoor activity and blocking UVB
photons are the two mechanisms that air pollution may lead to the reduction of VD cutaneous production. Increasing renal tubular dysfunction as well as down-
regulating the transcription of CYPs are major pathways that heavy metals may initiate to bring about the reduction of VD serum level. EDCs may inhibit the activity
and expression of CYPs. They may indirectly cause VDD through weight gain and the dysregulation of TH, PTH, and calcium homeostasis.
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3.5. Tobacco smoke
Tobacco smoke is a mixture of hazardous chemicals implicated in
the pathogenesis of a wide range of diseases. Owing to the presence of
toxicologically harmful compounds, such as PAHs, aldehydes, and DDT,
the smoke is carcinogen, neurotoxic, and endocrine disrupter
(Diamanti-Kandarakis et al., 2009; Smith and Hansch, 2000). As men-
tioned above, a large number of studies have been conducted on the
association of smoking and VDD where it has been one of the de-
terminants of VDD. In this review, we focused on the effect of all types
of smoking exposure on VDD, whether active or passive. Growing evi-
dence affirms the disruptive role of this notorious blend in VDES. The
incidence and prevalence of hypovitaminosis D among Norwegian
adults (Larose et al., 2014), Belgium pregnant women (Vandevijvere
et al., 2012), north European elderly women (Andersen et al., 2005),
middle-aged and elderly Chinese individuals (Zhen et al., 2015), south
Europeans (Cutillas-Marco et al., 2012) young Finnish adults (Lamberg-
Allardt et al., 2001), young and middle-aged Greek males (Kassi et al.,
2015), elderly Italian women (Isaia et al., 2003) and Spanish newborns
(Díaz-Gómez et al., 2007) have been attributed to the exposure to to-
bacco smoke as an endocrine-disrupting risk factor. Unlike air pollu-
tants, which principally have a significant effect on the photosynthesis
of cholecalciferol, based on epidemiological, in vitro and in vivo stu-
dies, it appears that smoking effect could be attributed to the enzymatic
and hormonal production of the subsequent metabolites.
An increased risk of hypovitaminosis D has been detected among
smokers versus non-smokers (odds ratio: 1.8; 95% confidence interval:
1.00–3.35). Smoking also has been correlated negatively with the
serum level of PTH (r=−0.24; P < 0.001) (Cutillas-Marco et al.,
2012). There are strong evidences asserting the suppressive role of to-
bacco smoke in the production of PTH, cholecalciferol, and calcitriol
(Brot et al., 1999; Cutillas-Marco et al., 2012; Jorde et al., 2005; Need
et al., 2002; Supervia et al., 2006). In light of findings emanated from
studies performed in this domain, the decrease of serum level of VD is
proportionate to depression in the PTH level in smokers (Need et al.,
2002). In fact, the key point is chaos in the interrelated regulation of VD
and PTH levels, which results in the disruption of the VD metabolism.
Hence, the dysfunctional vitamin D-PTH axis has been proposed as a
common impairment, which occurs under tobacco smoke exposure. By
using recorded data in the Tromsø study, the serum level of PTH was
evaluated in 7896 subjects consisting of smokers and non-smokers.
After correcting for confounding variables, the serum PTH levels were
significantly lower in smokers compared with non-smokers (3.1 ± 1.4
vs 3.6 ± 1.9 pmol/l in males; 3.1 ± 1.5 vs 3.6 ± 1.8 pmol/l in fe-
males (P, 0.001)) (Jorde et al., 2005). Reduced levels of iPTH among
smokers have been described in young and old individuals
(Gudmundsson et al., 1987; Landin-Wilhelmsen et al., 1995). Moreover,
lower intake of VD, decreased levels of S-25(OH)D, and decreased
calcium absorption among smokers. Interestingly, one year after
smoking cessation, serum levels of PTH have been similar to never
smokers (Jorde et al., 2005). Similar results have been obtained in a
cross-sectional study conducted by Brot and colleagues. They assessed
the effect of smoking on serum VD metabolites and PTH in a cohort of
510 healthy Danish perimenopausal women. In comparison to non-
smokers, current smokers (50% of the cohort) had significantly reduced
levels of serum 25(OH)D3 (P=0.02), 1,25(OH)2D3 (P=0.001), and
PTH (P < 0.001). They further reported a disruption in the vitamin-
PTH system among smokers, which was not explicable via lifestyle
factors other than smoking; it was considered a crystal clear explana-
tion for the harmful effect of smoking on osteoporosis in smokers (Brot
et al., 1999). It is of interest that S-25(OH)D and osteocalcin have
shown an inverse relationship with the number of smoked cigarettes per
day in premenopausal women, which may accelerate the rate of bone
loss (Hermann et al., 2000). Recently, a Chinese cohort with 612 older
men reported a dose-response pattern between lower serum con-
centrations of VD and greater number of smoked cigarettes per day,
longer smoking duration, and more pack-years (Jiang et al., 2016).
Such results support the inverse association between VDD and smoking.
However, further studies are needed to confirm such pattern between
smoking and serum levels of PTH.
Although the observed inverse association has been significantly
reported among women in general and older ones in particular, the
mentioned relationship between exposure to tobacco smoke and VDD is
not confined to a specific age group or particular gender. Kassi et al.
carried out a research on the relationship between the prevalence of
VDD and lifestyle parameters including smoking in healthy young and
middle-aged men. They observed a strong correlation between 25(OH)
D3 and smoking in participants (P < 0.001). By the help of a multi-
nomial logistic regression model, they showed that the probability of
having vitamin D3 inadequacy has increased in smokers up to 58% and
63% for 20–29 year and 40–50-year age subgroups, respectively, com-
pared with non-smokers (Kassi et al., 2015). Maternal exposure to to-
bacco smoke during pregnancy can affect VD level and subsequently
calcium metabolism in mothers and infants (Banihosseini et al., 2013;
Díaz-Gómez et al., 2007; Khuri-Bulos et al., 2014; Lawlor et al., 2013).
Diaz-Gomez and colleagues evaluated the effects of smoking on the
vitamin D-PTH system during the perinatal period. In their cohort study
with 61 mothers and newborns, declined serum levels of PTH in both
mothers and neonates, as well as a significantly lower levels of 25(OH)
D in neonates were observed (Díaz-Gómez et al., 2007). These findings
have been also seen in another prospective cohort study where 7.6% of
mothers reported a history of smoking in the gestational period and
72.4% of all mothers reported passive exposure to tobacco smoke
during pregnancy. Their results showed that the prevalence of severe
VDD in newborns was associated with maternal smoke exposure (Khuri-
Bulos et al., 2014). In addition, those mothers who have smoked during
their pregnancy had lower 25(OH)D levels across all their trimesters
compared with non-smokers (Lawlor et al., 2013). In a most recent
study, Chinellato and colleagues studies the association between S-
25(OH)D level and parental smoking in 152 children who were suf-
fering from asthma. Children with both nonsmoking parents benefited
from a significantly higher serum level of 25(OH)D than those with
both smoking parents (median of 20.5 ng/ml vs median of 14.5 ng/ml;
P < 0.001) (Chinellato et al., 2018).
In addition to the depression of serum levels of VD metabolites, it
has been shown that exposure to tobacco smoke can influence the in-
take of VD as well. A population-based survey of 2319 women con-
ducted by Morabia et al. in Switzerland showed that tobacco smoke
could cause the low intake of VD through changing the dietary taste
(Morabia et al., 2000). Furthermore, VD malabsorption might be a
possible hypothesis that needs experimental investigations to be testi-
fied. It is worth noting that after a long time (5 years) smoking cessa-
tion, similar intake of VD and calcium has been reported in both former
and never smokers (Morabia et al., 2000). On the other hand, the im-
pact of smoking quitting on maintaining or even increasing serum VD
levels described in some studies confirms the crucial importance of
tobacco smoke exposure in dysregulating VDES (Gilman et al., 2006;
Jiang et al., 2016). Jiang and colleagues revealed that longer duration
of smoking cessation (> 20 years) could result in higher VD levels in
former smokers compared with current smokers (P for trend= 0.04)
(Jiang et al., 2016). A related point to consider is the corrective action
of smoking quitting in relation to the calcitriol-PTH axis. Indeed, un-
desirable changes imposed on vitamin D-PTH system by smoking could
be reversible by smoking ceases (Need et al., 2002).
Accumulating evidence suggests the effect of smoking on the dete-
rioration of different disorders interrelated to VD levels. It means ex-
posure to tobacco smoke influences the state of a disease through the
alteration of VD metabolism. Gestational diabetes risk (Dodds et al.,
2016), activating Crohn's disease (Gilman et al., 2006; Jørgensen et al.,
2013), high rates of depression (Ren et al., 2016), the risk of myocardial
infarction (Deleskog et al., 2012), and increased markers of in-
flammation in HIV-infected individuals (Legeai et al., 2013) might be
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associated with lower VD levels triggered by smoking. Significant and
independent association between smoking and 25(OH)D concentrations
has been reported in current-smoking patients (Deleskog et al., 2012;
Jørgensen et al., 2013; Legeai et al., 2013). Through a case-control
study, Dodds et al. revealed an inverse correlation between VD status
and gestational diabetes, especially among women who smoked during
pregnancy (Dodds et al., 2016). This inverse association was also re-
ported among two cohorts of HIV-infected individuals between tobacco
use and severe VDD [25(OH)D<10 ng/ml] (Legeai et al., 2013;
Wasserman and Rubin, 2010). In two studies exploring the relationship
between VD status and smoking in patients with acute ischemic stroke
and myocardial infarction, VD concentrations were significantly lower
in smokers compared with non-smokers.
3.5.1. Tobacco smoke can potentially target almost all points of VDES
Although the mechanisms through which smoking interrupts the VD
metabolism is poorly defined and still remain unknown, on the ground
of the foregoing evidence summarized in the Table 2, making some
highly likely assumptions is presumably by the help of a chain of ex-
perimental-based deductive reasoning.
The sufficiency of serum VD level plays a decisive role in the bone
health subsequent to calcium intake and serum parathyroid hormone
levels. Under normal conditions, serum 25(OH)D and 1,25(OH)2D le-
vels are negatively correlated with the serum level of PTH (Cheng et al.,
2003; Holick, 2006). Through a cross-sectional study with 944 healthy
participants divided into three groups of age (30–45 years, 50–65 years,
and 70–85 years), calcium intake (< 800mg/d, 800–1200mg/d,
and<1200mg/d), and S-25(OH)D level (< 10 ng/ml, 10–18 ng/ml,
and<18 ng/ml), Steingrimsdottir et al. evaluated the importance of
high levels of 25(OH)D and calcium intake in serum intact PTH (iPTH).
After adjustment for relevant factors, such as smoking, it was observed
that serum PTH was lowest in the group with a serum 25(OH)D level
of> 18 ng/ml but highest in the group with an S-25(OH) D level
of< 10 ng/ml. They revealed that at low S-25(OH)D level (< 10 ng/
ml), the calcium intake of< 800mg/d vs> 1200mg/d was sig-
nificantly associated with higher serum PTH (P=0.04)
(Steingrimsdottir et al., 2005). Therefore, they reasoned that VD ade-
quacy is much more important than high calcium intake in maintaining
the optimum level of serum PTH. Accordingly, in response to the de-
creased level of VD, an increase in PTH level is expected; however,
under exposure to tobacco smoke serum levels of both 25(OH)D and
PTH have been lowered markedly (Brot et al., 1999; Cutillas-Marco
et al., 2012; Jorde et al., 2005; Need et al., 2002; Supervia et al., 2006).
Hypoparathyroidism has been discovered in both mother and their
newborns under maternal smoking (Díaz-Gómez et al., 2007). It has
been speculated that the dropped level of PTH in individuals exposed to
tobacco smoke may be as a result of a small unmeasurable change in
serum ionized calcium, a reduction in secretion or a rise in degradation
of the hormone (Brot et al., 1999; Need et al., 2002). Due to the pre-
sence of endocrine disrupters in tobacco smoke, it is expected to see
smoking-derived deleterious impacts on the VDES similar to the case
regarding the reduction of vitamin D-PTH axis. Notably, in comparison
to nonsmokers, smokers suffer from a significant decline in BMD caused
by the impairment of calcium absorption, which in turns is attributed to
the imposed destructive changes on vitamin D-PTH system (Brot et al.,
1999; Jorde et al., 2005; Need et al., 2002). The association between
lower BMD and smoking along with the declined concentration of VD
have been described in current and former smokers (Lorentzon et al.,
2006; Szulc et al., 2002). In line with the abovementioned studies, re-
cent observations have demonstrated that lower concentrations of
steroid hormones, as well as 25(OH)D, are associated with passive and
active cigarette smoking (Lorentzon et al., 2006; Shinkov et al., 2015;
Soldin et al., 2011; Szulc et al., 2002). There is further evidence based
on a cross-sectional study of 405 postmenopausal women where poor
calcium absorption in smokers has been associated with declined level
of PTH (which leads to decreased renal hydroxylation of the storage
form of VD to active structure) (Need et al., 2002).
Acrolein is an environmentally ubiquitous volatile organic com-
pound (VOC) (Amini et al., 2017). This unsaturated aldehyde is re-
sponsible for a considerable part of cellular and molecular adverse ef-
fects of tobacco smoke. Through an in vitro study, the effects of
cigarette smoking extract (CSE) and acrolein on the conversion of
25(OH)D3 to 1,25(OH)2D3 were separately studied by Hansdottir and
colleagues. They found that both of them had the capability to sig-
nificantly reduce the generation of active vitamin D3 in the airway
epithelial cells. It is of note that the effects of CSE and acrolein were
reversed by the enzyme aldehyde dehydrogenase (Hansdottir et al.,
2010). This enzyme catalyzes the oxidation of aldehydes by addition of
oxygen rather than by removal of hydrogen—that is, it converts alde-
hydes to carboxylic acids (Marchitti et al., 2008). The reduction of
1α‑hydroxylase under exposure to CSE was observed as well. Conse-
quently, lower level of 1,25(OH)2D3 could contribute to the over-
expression of inflammatory factors in smokers (Hansdottir et al., 2010).
In a similar investigation, Mulligan et al. genetically scrutinized the
effect of cigarette smoke (CS) on the levels of vitamin D3 and its con-
version to bioactive form in patients with chronic rhinosinusitis. They
found that CS could impair the capability of epithelial cells in the
conversion of 25(OH)D3 to 1,25(OH)2D3 by the downregulation of
CYP27B1 expression. CS exposure also was associated with declined
circulating level of 25(OH)D3 (Mulligan et al., 2014). In vivo and in
vitro exposure to other components of tobacco smoke such as nicotine
and Benzo[a]Pyrene (BaP) can decrease body storage of 25(OH)D and
1,25(OH)2D (Fung et al., 1999; Fung et al., 1998; Iwaniec et al., 2002;
Matsunawa et al., 2009). By using an array of research, Fung et al.
demonstrated that long- and short-term treatment with nicotine, the
principal and addictive alkaloid in tobacco, significantly decreased S-
25(OH)D in female rats (Fung et al., 1999; Fung et al., 1998; Iwaniec
et al., 2002). Interestingly, such negative correlation between VD serum
concentrations (< 20 ng/ml) and serum cotinine, the main metabolite
of nicotine, has been reported among American females with different
ethnic backgrounds. Based on the results, female active-smokers have
the lowest mean VD concentration and higher prevalence of VD defi-
ciency and inadequacy within the overall population in the U.S.
(Manavi et al., 2015). 24‑Hydroxylase is a member of the cytochrome
P450 superfamily of enzymes encoded by the CYP24A1 gene involved
in the metabolism of VD. It catalyzes reactions including 24‑hydro-
xylation of 25(OH)D and 1,25(OH)2D3 resulting in VDD. SNP
rs4809957, located in the 3′ untranslated region of CYP24A1 at
20q13.2, interacts with smoking dose (Dong et al., 2012). Moreover,
BaP, a PAH found in tobacco smoke, increases the catabolism of
1,25(OH)2D3 in human monocyte/macrophage-derived THP-1 cells by
enhanced expression of CYP24A1. In other words, BaP enhances the
production of 25‑hydroxyvitamin D3 24 hydroxylase (CYP24A1), which
leads to inactive metabolites of 24,25(OH)2D and 1,24,25(OH)3D, and
consequently decreased serum level of VD (Fig. 4) (Matsunawa et al.,
2009). Indeed, dysregulation of genes that encode those enzymes in-
volved in VD metabolism would be one of the possible mechanisms
engaged in tobacco smoke-originated VDD.
Skin plays the most important role in the provision and metabolism
of VD. Smoking (Ernster et al., 1995) and solar ultraviolet radiation
(Pillai et al., 2005) have been known as extrinsic factors inducing an
aging effect on human skin. Facial wrinkling is a marker of skin aging.
Lopez Hernandez et al. discovered strong evidence of accelerated skin
aging among smokers. They found a statistically remarkable effect of
smoking habit (OR=3.1; 95% CI=1.28–7.76; P=0.008), sun ex-
posure (OR=1.50; 95% CI=1.25–1.80; P=0.05), and age
(OR=1.18; 95% CI=1.13–1.23; P=0.024) on facial wrinkling
(López et al., 1995). Increasing skin aging can diminish the capability of
skin in the conversion of 7-DHC to precholecalciferol substantially
(Holick, 1995). Using a cross-sectional study of 299 never smokers, 551
former smokers and 286 current smokers, a positive association be-
tween pack-years smoking and facial wrinkle score has been revealed.
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The relative risk of moderate/severe wrinkling was estimated for cur-
rent men smokers as 2.3 (95% confidence interval CI= 1.2, 4.2)
compared to women never smokers 3.1 (95% CI=1.6, 5.9) (Ernster
et al., 1995). Mechanistically, the induction of matrix metalloprotei-
nases (MMPs) mediates photo aging. Concerning tobacco smoke, there
is adequate evidence putting an emphasis on the reinforcing role of
smoking in skin aging through activation of MMPs (Holick, 1995;
Lahmann et al., 2001). A significant increase of MMP-1 mRNA has been
reported in the skin of smokers compared with non-smokers, whereas
no difference has been seen for the tissue inhibitor of MMP-1 (Lahmann
et al., 2001). It should be pointed out that smoker patients with chronic
obstructive pulmonary disease (COPD) are at high risk of VDD because
they are more susceptible to skin aging (Janssens et al., 2010). Overall,
since smokers are more prone to skin aging, it is anticipated that
smoking-derived skin aging causes VDD through the disturbance in the
cutaneous production of vitamin D3.
The declined level of serum 1,25(OH)2D observed in smokers might
also be as a result of cadmium accumulation in the kidneys (Brot et al.,
1999; Kido et al., 1989). Since the tobacco plant has a considerable
capability to concentrate heavy metals in general (Cd and Pb in parti-
cular), tobacco smoke is one of the common and rich sources of Cd and
Pb exposure (Lugon-Moulin et al., 2006). Accordingly, inhibiting VD
activation mediated by Cd and Pb poisoning can be one of the me-
chanisms involved in VDD. Impaired kidney function is the central core
of this pathway. Indeed, there are elevated serum cadmium and lead
levels in smokers, which results in the deterioration of renal tubular
function and glomerular dysfunction (Cooper, 2006).
Putting experimental and epidemiological findings together, as
shown in Fig. 4, skin aging, simultaneous decrease of VD and PTH,
disturbance in the intake of dietary VD, renal tubular dysfunction, and
dysregulation of CYPs genes related to the metabolism of VD are most
possible pathways that interfere with VDES via exposure to tobacco
smoke. In Fig. 4, we have integrated all mentioned mechanisms in order
to provide a comprehensive view of a wide, and to some extent
independent, mechanisms that might lead to VDD. Accordingly, there is
an internationally emerging consensus among researchers corrobor-
ating the claim that smoking enhances the risk of VDD and severe VDD.
Nonetheless, further investigation in the genetic analysis of suspected
CYPs enzymes is needed to clearly ascertain metabolic mechanisms
responsible for the reported smoking-derived VDD.
4. Summary and conclusion
This review integrated various pieces of evidence that exposure to
air pollution, environmental chemicals, and smoking (with endocrine
disrupting properties) can negatively interfere VDES and in most cases
lead to VDD. To the best of our knowledge, the possible mechanisms
that may be more likely disturbed and induce low serum levels of VD
include: (1) decreased intestinal intake of VD, (2) decreased cutaneous
production of cholecalciferol, (3) the modulation of genes involved in
VD homeostasis, particularly CYPs, and (4) decreased local production
of calcitriol in target tissues. Nevertheless, we still need mechanistic
studies to explain precisely the biochemical pathways for mentioned
chemicals. Therefore, we are in need of conducting more epidemiologic
and experimental investigations on those sorts of environmental con-
taminants, which have the potency to cause VDD, so that involved
mechanisms would be delineated more clearly.
Based on the presented evidence and potential mechanisms, mon-
itoring serum level of VD in individuals with high exposure to the
mentioned stimuli, and consuming higher amount of VD fortified foods
and supplements by people settled in polluted areas are recommended
in order to minimize the detrimental impacts on VDES. It is expected
that the correction of VD status result into two vital achievements. First,
it ameliorates anti-inflammatory and anti-oxidative capabilities in
order to effectively deal with inflammatory-oxidative conditions origi-
nated from environmental toxicants. Second, such action averts the
dramatic decrease of serum VD under conditions of exposure to en-
vironmental contaminants, and maintains related biochemical
Fig. 4. Potential mechanisms related to the disruption of VDES by tobacco smoke. The positive and negative signs on the end of the arrows imply increasing and
decreasing the targets, respectively. Red arrows originated from the cigarette result in decreasing serum 25(OH)D and 1,25(OH)2D levels, VD intake from diet, and
the cutaneous production of VD. These four items determine the VD level of individuals. From a systematic point of view, cigarette smoke leads to depression of VD
levels in humans. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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pathways subsequent to keeping VDES well balanced. Accordingly,
since pregnant women, on the one hand, are susceptible to VDD, and on
the other hand, susceptible to environmental pollutants, recent in-
vestigations recommend a VD screening program and VD supple-
mentation for those pregnant women who need it. These actions po-
tentially could lead to a substantial decrease in related adverse
pregnancy outcomes, especially in environmentally polluted areas
(Holick, 2018; Rostami et al., 2018).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2018.11.052.
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